Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldInsilico Medicine
Categories
healthcaredrug-discoveryfoundation-models
HQBaltimore, Maryland, USA
Founded2014
Latest valuation—
Annual Recurring Revenue (ARR)—
Funding to date$500M+
Headcount180+
Profitability—
Statusactive
Pricing tierenterprise
DescriptionClinical-stage biotech using generative AI for end-to-end drug discovery. Proprietary Pharma.AI platform integrates LLMs, multimodal foundation model (Nach01), and Dora research assistant. First fully AI-discovered molecule in Phase 2 trials.